SEC Filing Summary: ChromaDex Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by ChromaDex Corporation on March 11, 2019. The filing serves as a Regulation FD disclosure regarding a corporate presentation released by the Company. This presentation was made available on the Company's website and utilized during the 39th Annual Cowen Health Care Conference held in Boston, Massachusetts on the same date.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts solely as a notice of the availability of an investor presentation (Exhibit 99.1) and does not contain embedded financial tables or numerical data.
Material Changes
No material changes to financial performance or operations are detailed within the text of this filing. The document references the attached presentation for further details but does not summarize comparative period data itself.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information furnished in Item 7.01 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, the content is not subject to the liability of that section nor incorporated by reference into other filings, except as expressly set forth by specific reference. No specific guidance, outlook, or risk factors are enumerated in the body of this report.
Key Facts for Investor Verification
- Verify the contents of the attached Exhibit 99.1 (Investor Presentation) for actual financial data and strategic updates.
- Confirm the date of the 39th Annual Cowen Health Care Conference presentation (March 11, 2019).
- Note that the information in this 8-K is furnished, not filed, limiting its legal incorporation into other SEC documents.
- Identify the signatory as Kevin M. Farr, Chief Financial Officer.